University of British Columbia

University of British Columbia has been granted 373 US utility patents between 2015 and 2025, placing University of British Columbia at rank #1,135 across all assignees tracked by PlainPatent. This portfolio spans 133 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.8 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, University of British Columbia is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 62.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 193 grants, compared with 180 in the 2015–2019 window — a +7% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. University of British Columbia's 20.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark University of British Columbia against peers pursuing similar technology classes.